aap Implantate AG aap Implantate AG: Changes in the Management Board
|
aap Implantate AG / Key word(s): Personnel decisions / Executive Board aap Implantate AG informs that Mr. Rubino Di Girolamo will resign from his position as a member of the Company’s Management Board, including the office of Chief Executive Officer/CEO, in agreement with the Supervisory Board, as of December 31, 2026 and will thus leave the Company’s Management Board prematurely. Today, the Supervisory Board appointed Mr. Cornelius Fink as a member of the Executive Board with immediate effect. Mr. Fink will assume responsibility for the Trauma division. In addition, the Supervisory Board today appointed Ms. Nicole Kassel as a member of the Board of Management with responsibility for Finance (CFO) with immediate effect. +++ Contact: aap Implantate AG; R. Di Girolamo; Vorsitzender des Vorstands / CEO; Lorenzweg 5; D-12099 Berlin Tel.: +49/30/750 19 – 170; Fax: +49/30/750 19 – 290; r.digirolamo@aap.de End of Inside Information
19-Aug-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | aap Implantate AG |
| Lorenzweg 5 | |
| 12099 Berlin | |
| Germany | |
| Phone: | +49 (0) 30 75 019-0 |
| Fax: | +49 (0) 30 75 019-111 |
| E-mail: | info@aap.de |
| Internet: | www.aap.de |
| ISIN: | DE000A3H2101 |
| WKN: | A3H210 |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate BSX |
| LEI Code: | 39120001TRQTQ01LPP57 |
| EQS News ID: | 2385282 |
| End of Announcement | EQS News Service |
|
|
2385282 19-Aug-2026 CET/CEST